Business · 03/02/2025Updated: 10/17/2026 · 1 min read
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biosimilars User Fee Program
Summary
The Food and Drug Administration (FDA) is announcing the submission of a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →